The Superior Central Nucleus (also known as the Dorsal Raphe Nucleus, DRN or linear nucleus of the midbrain) is a prominent serotonergic nucleus in the midbrain that plays crucial roles in mood regulation, arousal, sleep-wake cycles, and various autonomic functions. This page provides comprehensive information about its organization, function, and involvement in neurological disorders.
The superior central nucleus is one of the most prominent serotonergic cell groups in the mammalian brain. Located in the midbrain tegmentum along the midline, the DRN contains the largest concentration of serotonergic neurons in the brain and projects to virtually all forebrain regions[1]. The DRN is anatomically and functionally heterogeneous, comprising distinct subpopulations of serotonergic and non-serotonergic neurons that serve different circuit functions[2].
| Property | Value |
|---|---|
| Category | Midbrain Nucleus |
| Location | Midbrain, periaqueductal gray |
| Cell Type | Serotonergic neurons, GABAergic neurons, glutamatergic neurons |
| Primary Neurotransmitter | Serotonin (5-HT) |
| Key Markers | TPH2, SERT, 5-HT |
The DRN is divided into several subregions:
DRN contains:
The DRN is central to emotional regulation:
DRN modulates wakefulness:
DRN participates in endogenous pain control:
DRN receives input from:
DRN projects to:
The study of Superior Central Nucleus Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Parent A, Descarries L, Beaudet A. Organization of ascending serotonin systems in the adult rat brain. Journal of Comparative Neurology. 1981;203(2):269-283.
[2] O'Leary OF, Felice D, Galimberti S, Savignac HM, Bravo JA, Crowley T, El Yacoubi M, Vaugeois JM, Lucki I, Barden N, Gass P, Porteous R, Rani A, Dinan TG, Cao L, Micioni Di Bonaventura MV, Luca M, Clapcote SJ, Cryan JF. 5-HT2C receptor activation in the dorsal raphe nucleus is required for stress- and corticotropin-releasing factor-induced depression-like behavior. Neuropsychopharmacology. 2014;39(10):2456-2472.
[3] Stockmeier CA. Neurobiology of serotonin in depression and suicide. Annals of the New York Academy of Sciences. 1997;836:220-232.
[4] Jellinger KA. Prevalence of neuropathological lesions in the raphe nuclei in Parkinson's disease. Journal of Neural Transmission. 1991;85:39-47.
[5] Di Matteo V, Pierucci M, Esposito E. Selective serotonin reuptake inhibitors (SSRIs) and 5-HT2 receptors: role in pain and analgesia. Neurochemical Research. 2008;33(10):2015-2026.
[6] Nakamura K. The role of the dorsal raphe nucleus in reward-seeking behavior. Frontiers in Integrative Neuroscience. 2013;7:51.
[7] Deakin JF. Depression and 5-HT: a synthesis. Journal of Psychopharmacology. 2008;22(2):3-9.
[8] Jacobs BL, Fornal CA. Activity of brain serotonergic neurons in the behaving animal. Pharmacological Reviews. 1991;43(4):563-578.